课题基金 / 基金详情

STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4

STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4
NANOG、SOX2 和 OCT4 的结构和 DNA 结合研究
批准号:
8361239
负责人:
ASEEM Z ANSARI
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2012-02-29

项目摘要

项目成果

ASEEM Z ANSARI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. NANOG, Sox2 and Oct4 are transcription factors with key functions in mammalian stem cell biology. They are central of pluripotency in ES cells. Loss of NANOG induces differentiation towards an endoderm-like lineage in embryonic stem (ES) cells, whereas forced expression retains the ES phenotype in the absence of the otherwise essential growth factors. NANOG binds to promoter elements of hundreds of target genes and regulates their expression. The mechanism of this transcriptional regulation is not yet known. Currently, one X-ray crystal structure of the homeodomain of murine Nanog is available in the PDB; however, numerous studies have shown that the pathways maintaining pluripotency are different between human and mouse ES cells. We plan to determine the structure and DNA binding studies of NANOG, Sox2 and Oct4 by NMR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
Revealing Masked Specificities of Human Nuclear Receptors
Revealing masked specificities of human Nuclear Receptors
  • 批准号:
    9356561
  • 项目类别:
  • 资助金额:
    $34.39万
  • 财政年份:
    2016
  • 负责人:
    ASEEM Z ANSARI
  • 依托单位:
国内基金
海外基金
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究